 The first, for grass pollen allergy, was launched in 2006, and was followed by SLIT-tablets for ragweed pollen allergy in 2014 and house dust mite allergy in 2016.The company is part-owned by the Lundbeck Foundation, however is also a publicly traded entity.ALK’s stock is listed on the NASDAQ OMX Copenhagen Stock Exchange.